Abstract:
BACKGROUND:Nephroureterectomy alone fails to adequately treat many patients with advanced upper tract urothelial carcinoma (UTUC). Perioperative platinum-based chemotherapy has been proposed but requires adequate renal function. OBJECTIVE:Our aim was to determine whether the ability to deliver platinum-based chemotherapy following nephroureterectomy is affected by postoperative changes in renal function. DESIGN, SETTINGS, AND PARTICIPANTS:We retrospectively reviewed data on 388 patients undergoing nephroureterectomy for UTUC between 1991 and 2009. Four institutions were included. INTERVENTION:All patients underwent nephroureterectomy. MEASUREMENTS:All patients had serum creatinine measured before and after surgery. The value closest to 3 mo after surgery was taken as the postoperative value (range: 2-52 wk). Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease study equation. eGFR values before and after surgery were compared using the paired t test. We chose an eGFR of 45 and 60 ml/min per 1.73 m(2) as possible cut-offs for chemotherapy eligibility and compared eligibility before and after surgery using the chi-square test. RESULTS AND LIMITATIONS:Our cohort of 388 patients included 233 men (60%) with a median age of 70 yr. Mean eGFR decreased by 24% after surgery. Using a cut-off of 60 ml/min per 1.73 m(2), 49% of patients were eligible for chemotherapy before surgery, but only 19% of patients remained eligible postoperatively. Using a cut-off of 45 ml/min per 1.73 m(2), 80% of patients were eligible preoperatively, but only 55% remained eligible after surgery. This distribution persisted when we limited the analysis to patients with advanced pathologic stage (T3 or higher). Patients older than the median age of 70 yr were more likely to be ineligible for chemotherapy both pre- and postoperatively by either definition, and they were significantly more likely to have an eGFR <45 ml/min per 1.73 m(2) postoperatively, regardless of their starting eGFR. This study is limited by its retrospective nature, and there was some variability in the timing of postoperative serum creatinine measurements. CONCLUSIONS:eGFR is significantly diminished after nephroureterectomy, particularly in elderly patients. These changes in renal function likely affect eligibility for adjuvant cisplatin-based therapy. Accordingly, we suggest strong consideration of neoadjuvant regimens.
journal_name
Eur Uroljournal_title
European urologyauthors
Kaag MG,O'Malley RL,O'Malley P,Godoy G,Chen M,Smaldone MC,Hrebinko RL,Raman JD,Bochner B,Dalbagni G,Stifelman MD,Taneja SS,Huang WCdoi
10.1016/j.eururo.2010.06.029subject
Has Abstractpub_date
2010-10-01 00:00:00pages
581-7issue
4eissn
0302-2838issn
1873-7560pii
S0302-2838(10)00562-2journal_volume
58pub_type
杂志文章,多中心研究相关文献
EUROPEAN UROLOGY文献大全abstract::Hormonal therapy represents first-line treatment for patients with advanced prostate cancer. Generally, surgical castration is viewed as the 'gold standard' but carries with it a psychological effect. Medical alternatives include LHRH analogues, antiandrogens, and oestrogens, though the last of these is associated wit...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000475049
更新日期:1995-01-01 00:00:00
abstract:PURPOSE:To evaluate the impact of androgen deprivation on health related quality of life (HRQOL) in patients with asymptomatic lymph node positive prostatic carcinoma (LPPC). MATERIALS AND METHODS:HRQOL domains were measured, using standard instruments in 91 patients with histologically proven LPPC. Most patients were...
journal_title:European urology
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1016/s0302-2838(03)00208-2
更新日期:2003-08-01 00:00:00
abstract:BACKGROUND:Pretreatment tables for the prediction of pathologic stage have been published and validated for localized prostate cancer (PCa). No such tables are available for locally advanced (cT3a) PCa. OBJECTIVE:To construct tables predicting pathologic outcome after radical prostatectomy (RP) for patients with cT3a ...
journal_title:European urology
pub_type: 杂志文章,多中心研究
doi:10.1016/j.eururo.2014.03.013
更新日期:2015-02-01 00:00:00
abstract:BACKGROUND:It is unknown whether lymph node metastases (LNM) and their localization negatively affect clinical outcome in metastatic renal cell carcinoma (mRCC) patients. OBJECTIVE:To evaluate the clinicopathological features, survival outcome, and treatment response in mRCC patients with LNM versus those without LNM ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2014.11.054
更新日期:2015-09-01 00:00:00
abstract::Changing demography and expectations about maintaining quality of life mean that an increasing number of men will require treatment for benign prostatic hyperplasia (BPH). Many growth factors have a role in the development of BPH. Consequently growth factor antagonists offer an attractive therapeutic option. In double...
journal_title:European urology
pub_type: 杂志文章,评审
doi:
更新日期:1997-01-01 00:00:00
abstract:BACKGROUND:Inherited DNA-repair gene mutations are more prevalent in men with advanced prostate cancer than previously thought, but their clinical implications are not fully understood. OBJECTIVE:To investigate the clinical significance of germline DNA-repair gene alterations in men with metastatic castration-resistan...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2018.01.035
更新日期:2018-08-01 00:00:00
abstract:OBJECTIVE:This open-label extension study evaluated the efficacy and safety of tamsulosin (0.4 mg as a modified release formulation) once daily in patients with benign prostatic enlargement, lower urinary tract symptoms and benign prostatic obstruction (symptomatic BPH) for up to 60 weeks. METHODS:Patients were enroll...
journal_title:European urology
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:
更新日期:1996-01-01 00:00:00
abstract::In making treatment decisions for patients with benign prostatic hyperplasia (BPH), physicians have to rely on the efficacy data published in the literature and adapt this to individual patient's needs. Criticism can be made, however, of the randomised clinical trials (RCTs) that are performed, as the patients enrolle...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000049884
更新日期:2001-01-01 00:00:00
abstract:OBJECTIVES:Based on a recently introduced mathematical model approach we show that uroliths located in the urinary tract (UT) can substantially deplete the urinary concentrations of lithogenic constituents by continuous growth. METHODS:To illustrate the influence of the urinary depletion effect on urinalysis, a "typic...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/s0302-2838(03)00365-8
更新日期:2003-11-01 00:00:00
abstract::Six methods for prevention of renal arterial vasospasms, due to extensive surgical trauma are compared in an experimental study in rats. The 'proximal transit time' was chosen as a measure for renal arterial flow 1, 5, 10 and 15 min after a standard surgical trauma. Xylocaine infiltration around the renal pedicle was ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000473224
更新日期:1981-01-01 00:00:00
abstract::9 case of needle tract seeding following percutaneous puncture of an avascular mass, which proved to be a retroperitoneal liposarcoma, is presented. ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000474128
更新日期:1983-01-01 00:00:00
abstract:OBJECTIVES:Multifocality and frequent recurrence of urothelial carcinoma of the urinary bladder indicate a disease of the entire "urothelial field", but little is known about chromosomal alterations in histologically normal urothelium. Histopathologically normal urothelium from patients with and without concurrent urot...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2004.07.012
更新日期:2005-01-01 00:00:00
abstract:BACKGROUND:In Alpharadin in Symptomatic Prostate Cancer (ALSYMPCA) trial, radium-223 versus placebo prolonged overall survival with favorable safety in castration-resistant prostate cancer patients with symptomatic bone metastases. Long-term radium-223 monitoring underlies a comprehensive safety and risk/benefit assess...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2017.06.021
更新日期:2018-03-01 00:00:00
abstract:OBJECTIVES:To determine the efficacy, safety and feasibility of intermittent androgen deprivation (IAD) in patients with prostate-specific antigen (PSA) relapse after radical prostatectomy or with an incidental prostate cancer (pT1B) after transurethral resection of the prostate (TURP). METHODS:Open, nonrandomized, pr...
journal_title:European urology
pub_type: 杂志文章
doi:
更新日期:1999-01-01 00:00:00
abstract:BACKGROUND:Management of recurrent prostate cancer (CaP) after radiotherapy (RT) is dependent on accurate localization of the site of recurrent disease. OBJECTIVE:To describe the anatomic patterns and clinical features associated with CaP recurrence following RT identified on advanced imaging. DESIGN, SETTING, AND PA...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2016.08.055
更新日期:2017-03-01 00:00:00
abstract:BACKGROUND:Clear cell renal cell carcinomas (ccRCC) frequently display a loss of function of the von Hippel-Lindau (VHL) gene. OBJECTIVE:To elucidate the putative relationship between VHL mutation status and immune checkpoint ligand programmed death-ligand 1 (PD-L1) expression. DESIGN, SETTING, AND PARTICIPANTS:A ser...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2015.11.029
更新日期:2016-10-01 00:00:00
abstract::A case of multiple bilateral renal angiomyolipomas, associated with renal artery dysplasia and a solitary benign pulmonary tumour, in a woman with no evidence of tuberous sclerosis, is described. ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000472637
更新日期:1986-01-01 00:00:00
abstract:OBJECTIVES:Pelvic lymph node metastases indicate a poor prognosis for patients with clinically localized prostate cancer. The aim of the study was to investigate the value of extended histopathological techniques considering the extent of pelvic lymphadenectomy and preoperative risk factors. METHODS:Total of 194 patie...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/s0302-2838(02)00450-5
更新日期:2003-02-01 00:00:00
abstract::The autoimmune features of interstitial cystitis are reviewed. Despite some controversy, interstitial cystitis should be grouped to the connective tissue diseases but as a separate entity. ...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1159/000473278
更新日期:1980-01-01 00:00:00
abstract:OBJECTIVES:To evaluate the relative accuracy of a computerised method to quantitatively assess maximum urinary flow. METHODS:A total of 1147 uroflows were evaluated by the computerised method and by three experts from different European countries. The sample consisted of uroflows from the respective visits by a 20% sa...
journal_title:European urology
pub_type: 临床试验,杂志文章,多中心研究,随机对照试验
doi:10.1016/s0302-2838(01)00037-9
更新日期:2002-02-01 00:00:00
abstract::We report on a patient who developed a urethrogluteal fistula 11 years following cystectomy performed for carcinoma of the bladder. The diagnosis was established by retrograde urethrography and fistulography. To the best of our knowledge, no previous case has been reported in the literature. ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000472777
更新日期:1987-01-01 00:00:00
abstract:BACKGROUND:Cyclic high-dose testosterone injections, also known as bipolar androgen therapy (BAT), is a novel treatment strategy for patients with metastatic castration-resistant prostate cancer (mCRPC). BAT has shown clinical activity in prior studies enrolling men with mCRPC and may potentially restore sensitivity to...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2020.06.042
更新日期:2020-07-02 00:00:00
abstract::Side-effects are commonly manifested during intravesical Bacillus Calmette-Guérin (BCG) immunotherapy of superficial bladder cancer. This often causes delays or interruptions of the instillations and consequently reduces the efficacy of treatment. Treatment strategies aimed at reducing the side-effects of BCG immunoth...
journal_title:European urology
pub_type: 临床试验,杂志文章,随机对照试验
doi:10.1159/000052380
更新日期:2000-01-01 00:00:00
abstract:OBJECTIVES:Lymphoma is the most frequent testicular malignancy in men over 60 years of age. Even though patients present initially with localized disease, the high incidence of bilateral involvement, synchronous or not, and early systemic dissemination are characteristic of these neoplasms. Sometimes the interval betwe...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000020378
更新日期:2000-12-01 00:00:00
abstract:BACKGROUND:Metastatic castration-resistant prostate cancer (mCRPC) is the lethal form of the disease. Several recent studies have identified genomic alterations in mCRPC, but the clinical implications of these genomic alterations have not been fully elucidated. OBJECTIVE:To use whole-genome sequencing (WGS) to assess ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2019.03.020
更新日期:2019-11-01 00:00:00
abstract:OBJECTIVES:To assess and compare the risk of prostatic surgery in (subsets of) patients with a diagnosis of BPH. We sought to expand on data of an earlier pharmacy-based study by obtaining more information on BPH disease parameters by using a Dutch GP-based research database. METHODS:A retrospective cohort study (1994...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2004.11.001
更新日期:2005-04-01 00:00:00
abstract:CONTEXT:Because pelvic lymph node (LN)-positive prostate cancer (PCa) is generally considered a regionally metastatic disease, surgery needs to be better defined. OBJECTIVE:To review the impact of radical prostatectomy (RP) and pelvic lymph node dissection (PLND), possibly in conjunction with a multimodal approach usi...
journal_title:European urology
pub_type: 杂志文章,评审
doi:10.1016/j.eururo.2013.05.033
更新日期:2014-08-01 00:00:00
abstract:BACKGROUND:Limited data exist on long-term outcomes among men with prostate cancer (PCa) from population-based cohorts incorporating information on clinical risk category. OBJECTIVE:To assess 15-yr mortality for men with PCa treated with noncurative intent according to clinical stage, Gleason score (GS), serum levels ...
journal_title:European urology
pub_type: 杂志文章
doi:10.1016/j.eururo.2012.08.001
更新日期:2013-01-01 00:00:00
abstract::Neurogenic dyssynergia was treated with alpha-adrenergic blockers. Only 21 of 43 highly selected patients with residual urines and low flow rates continued therapy with phenoxybenzamine for more than 6 months, despite initial benefits. The causes of therapy discontinuation are discussed. A combination of 5 mg dibenzyl...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000474074
更新日期:1983-01-01 00:00:00
abstract::We have studied 38 patients with previously untreated, widespread prostatic cancer, who were submitted to therapy with cyproterone acetate and orchiectomy. 70% of patients with symptoms have shown subjective improvement. Moreover, it was possible to observe the regression, stabilization or progression of metastases in...
journal_title:European urology
pub_type: 杂志文章
doi:10.1159/000473314
更新日期:1980-01-01 00:00:00